A medical doctor by training, Bokhari was appointed co-chairman of Toronto-headquartered FSD Pharma in October. From this position, he intends to help lead the company, a licensed producer of marijuana, as it ventures further into the business of medical cannabis. In October, FSD Pharma announced it acquired Nasdaq-listed Therapix Biosciences Ltd., a clinical-stage Israeli developer of cannabinoid-based drugs, for $48 million worth of FSD Pharma stock—nearly three times its market value. It was one of the first deals Bokhari oversaw as the co-chairman of the company. FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed

thumbnail courtesy of calcalistech.com